ArticleOncotarget2016

HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinoma.

Dan-Chun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.